Optimize Analytical Method Development Strategies

Online Registration is open!

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200

Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Advanced Search

Home»Events»Optimize Analytical Method...Event Overview»Main Conference Day One

Optimize Analytical Method Development Strategies

June 26 - 28, 2007 | The Ritz-Carlton Philadelphia, Philadelphia, PA

Main Conference Day One

Wednesday, June 27th, 2007

8:00	Registration & Morning Coffee
8:45	Chairperson's Welcoming Remarks Susan J. Schniepp, Manager, Compendial Compliance, HOSPIRA Fred Rabel, PhD, former Marketing/Technical Manager, EMD CHEMICALS, a division of Merck KGaA and President, CHROMHELP, INC.
9:00	Exploiting Forced Degradation Studies to Develop a Stability-Indicating HPLC Method: The Chicken or the Egg Paradox Tessi Kanavarioti, PhD, Sr. Scientist, Pharmaceutical Sciences, AFFYMAX, INC.
9:45	Emerging Technologies for Pharmaceutical Impurity Detection and Characterization Qingxi Wang, PhD, Director, Global Pharmaceutical Commercialization, MERCK & COMPANY
10:30	30 Minute Networking and Refreshment Break
11:00	CASE STUDY Effective and Efficient Method Development using Snyder Dolan's Column Database Yun Mao, PhD, Research Fellow, MERCK & COMPANY
11:45	CASE STUDY Optimization of Static Headspace Capillary Gas Chromatography for Rapid Determination of Formaldehyde and Acetaldehyde in Pharmaceutical Excipients Laura K. Jacobus, Staff Chemist, MERCK & COMPANY
12:30	Luncheon
1:45	CASE STUDY Develop and Validate Analytical Methods for Genotoxic Impurities Shufang Niu, PhD, Senior Research Investigator II, Schering Plough
2:30	CASE STUDY Determine, Test and Control Impurities that Possess Potential for Genotoxicity using Staged TTC Approach Tao Wang, PhD, Director, MERCK & COMPANY
3:15	30 Minute Networking and Refreshment Break
3:45	CASE STUDY Development of a Rapid Method for Simultaneous Determination of Potency and Impurities of Anionic, Cationic, and Neutral Metal Complexes David Loffredo, PhD, Manager, Global Product Development, HOSPIRA
4:30	PANEL DISCUSSION Orthogonal Methods-What are the Most Appropriate Testing Tools for Method Development? Laura K. Jacobus, Staff Chemist, MERCK & COMPANY Yun Mao, PhD, Research Fellow, MERCK & COMPANY Partha S. Mukherjee, PhD, Associate Principal Scientist, Pharmaceutical and Analytical R&D, ASTRAZENECA PHARMACEUTICALS LP Shufang Niu, PhD, Senior Research Investigator II, Schering Plough
5:15	Day One Concludes